Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) Inventory Average: 2016-2025

Historic Inventory Average for Collegium Pharmaceutical (COLL) over the last 9 years, with Sep 2025 value amounting to $38.1 million.

  • Collegium Pharmaceutical's Inventory Average rose 15.64% to $38.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.1 million, marking a year-over-year increase of 15.64%. This contributed to the annual value of $33.9 million for FY2024, which is 13.88% down from last year.
  • According to the latest figures from Q3 2025, Collegium Pharmaceutical's Inventory Average is $38.1 million, which was up 1.11% from $37.7 million recorded in Q2 2025.
  • In the past 5 years, Collegium Pharmaceutical's Inventory Average registered a high of $79.0 million during Q2 2022, and its lowest value of $15.6 million during Q1 2021.
  • In the last 3 years, Collegium Pharmaceutical's Inventory Average had a median value of $33.2 million in 2023 and averaged $34.2 million.
  • As far as peak fluctuations go, Collegium Pharmaceutical's Inventory Average surged by 349.99% in 2022, and later tumbled by 62.69% in 2023.
  • Quarterly analysis of 5 years shows Collegium Pharmaceutical's Inventory Average stood at $17.4 million in 2021, then skyrocketed by 219.85% to $55.6 million in 2022, then tumbled by 40.21% to $33.2 million in 2023, then climbed by 10.74% to $36.8 million in 2024, then climbed by 15.64% to $38.1 million in 2025.
  • Its last three reported values are $38.1 million in Q3 2025, $37.7 million for Q2 2025, and $36.4 million during Q1 2025.